Ross Acquisition Corp. II (ROSS) Mutually Terminates APRINOIA Deal
by Marlena Haddad on 2023-08-21 at 4:49pm

Ross Acquisition Corp II (NYSE:ROSS) announced this afternoon that it has mutually terminated its combination with drug developer APRINOIA, effective immediately.

The parties did not disclose why they decided to nix the deal and did not provide further details.

Ross II inked its $319 million business combination with APRINOIA in January, originally bringing about $350.6 million into the deal from its trust. It supplemented this with $12.5 million in convertible notes, $7.5 million of which were to be funded by an affiliate of the SPAC’s CEO, President and Chairman Wilbur Ross, and APRINOIA was expected to receive a $10 million strategic investment from a pharmaceutical partner.

However, the SPAC saw 81.5% of its trust redeemed during previous extension meetings, leaving it with $65.3 million post-vote. It remains unclear whether Ross II will continue to search for an alternative target to combine with or liquidate, but it currently faces a deadline just weeks away on September 16. 

Cambridge, Massachusetts-based APRINOIA is developing treatments and diagnostic tools for Alzheimer’s and Parkinson’s that target the toxic proteins that accelerate the diseases’ progression.

Recent Posts
by Marlena Haddad on 2023-12-08 at 9:42am

Legato Merger Corp. III (NYSE:LEGT) filed for a $175 million IPO yesterday afternoon, becoming the fourth SPAC to file this week. While the other three SPACs that filed their S-1s earlier this week intend to pursue targets in the financial services and biotech industries, Legato III, similar to the earlier Legato SPACs, will focus on...

by Nicholas Alan Clayton on 2023-12-08 at 7:48am

At the SPAC of Dawn This week ends with an unusually busy earnings calendar as 172 US-listed companies report quarterly figures today. Among them is Exela Technologies (NASDSAQ:XELA), which completed a combination with Quinpario 2 in 2017. The billing software company has gone on to do another SPAC deal on November 29, this time spinning...

by Marlena Haddad on 2023-12-07 at 10:38am

FG Merger III Corp. filed for a $150 million IPO yesterday afternoon, marking the third SPAC to file on Wednesday. Similar to Blue Room (NASDAQ:IBLUU), which filed its $200 million IPO yesterday morning, FG Merger III intends to focus its search for a target business in the financial services industry in North America. Notably, FG...

by Marlena Haddad on 2023-12-07 at 7:55am

10X Capital Venture Acquisition Corp. II (NASDAQ:VCXA) announced that it has completed its business combination with African Agriculture after shareholders approved the deal at a special meeting held on December 5. In connection with the meeting, 10X II received redemption requests for 1,857,033 Class A ordinary shares, representing 98.7% in aggregate redemptions since 10X II’s...

by Nicholas Alan Clayton on 2023-12-07 at 7:52am

At the SPAC of Dawn The latter half of 2023 has largely told a story of retrenchment in the SPAC market as much of the excess in the domain has found itself terminating and liquidating. But, the increase in outgoing has not completely canceled out the boom in incoming as three new SPACs filed to...


Copyright © 2023 SPACInsider, Inc. All Rights Reserved